Keyphrases
Chronic Kidney Disease
95%
Chronic Kidney Disease Patients
68%
Hemodialysis
56%
Surabaya
42%
COVID-19
39%
Mortality Prediction
32%
Systematic Meta-analysis
28%
Meta-analysis
28%
Indonesia
28%
Cardiovascular Mortality Risk
27%
Type 1 Diabetes Mellitus (T1DM)
27%
Hemodialysis Patients
25%
Maintenance Hemodialysis Patients
25%
Non-dialysis Chronic Kidney Disease
25%
Indonesian
24%
Cardiovascular Mortality
22%
Chronic Kidney Disease Stage
22%
Critically Ill COVID-19 Patients
21%
Referral Hospital
20%
Sarcopenia
20%
Asymmetric Dimethylarginine
19%
Risk Factors
18%
Hypertension
18%
Atherosclerotic Cardiovascular Disease (ASCVD)
17%
Estimated Glomerular Filtration Rate
15%
Proteinuria
15%
Intact Parathyroid Hormone (iPTH)
15%
Acute Kidney Injury
14%
Retrospective Cohort Study
14%
Lupus Nephritis
13%
8-hydroxydeoxyguanosine (8-OHdG)
13%
Carotid-femoral Pulse Wave Velocity (cfPWV)
13%
Myostatin
13%
Antihypertensive Drugs
13%
Disease Progression
13%
Insulin Resistance
13%
Elderly Patients
13%
Dialysate
13%
Angiotensin-converting Enzyme
13%
Interleukin-6 Levels
13%
N-acetylcysteine
13%
Non-tunneled Hemodialysis Catheter
13%
Gene Polymorphism
13%
Fungus Comb
13%
Ethyl Acetate
13%
Mortality Rate
12%
Serum Creatinine
11%
Length of Stay
11%
No Significant Difference
11%
Blood Urea Nitrogen
10%
D-dimer
10%
Angiotensin-converting Enzyme Inhibitor (ACEi)
10%
Ultrafiltration
10%
Hypertensive
10%
COVID-19 Patients
10%
Non-dialysis
9%
General Hospital
9%
Single nucleotide Polymorphism
9%
Atherosclerotic Cardiovascular Disease Risk Score
9%
Parathyroid Hormone Levels
9%
History of Hypertension
9%
Adult Patients
9%
End-stage Renal Disease
9%
Albumin
9%
Predictive Value
9%
Double-lumen Catheter
9%
Leukocytes
9%
Hyperkalemia
9%
Universitas
8%
Mellitus Diabetes
8%
Beta-blockers
8%
Maintenance Hemodialysis
8%
Nitrogen Levels
8%
Regular Hemodialysis
8%
Hypokalemia
8%
Kidney Transplantation
8%
Non-associated
8%
Arterial Stiffness
8%
Kidney
8%
Nephrology
8%
Radiological Parameters
8%
Bone Disorders
8%
Mineral Disorders
8%
Mesenchymal Stem Cells
8%
Polymorphism
8%
Mounds
8%
Termites
8%
Macrotermes Gilvus Hagen
8%
Randomized Controlled Trial
8%
Patency
8%
Narrative Review
7%
End-stage Renal Disease Patients
7%
Malnutrition
7%
PubMed
7%
Renal Disease
7%
Dialysis
7%
Serum Albumin
7%
High Dose
7%
Interleukin-6
7%
Non-survivors
7%
Medicine and Dentistry
Chronic Kidney Disease
100%
Hemodialysis
52%
COVID-19
20%
Systematic Review
20%
Diabetes Mellitus
18%
Mesenchymal Stem Cell
17%
Meta-Analysis
15%
N(g),n(g) Dimethylarginine
13%
Acute Kidney Injury
13%
Lupus Nephritis
13%
Sarcopenia
13%
Insulin Resistance
13%
Elderly Patient
13%
Dialysis Catheter
13%
Cardiovascular Mortality
13%
DNA Polymorphism
13%
Creatinine
13%
Cardiovascular Disease
13%
Cross Sectional Study
10%
Blood Urea Nitrogen
10%
Mixed Infection
10%
Diseases
10%
Hyperkalemia
9%
Proteinuria
8%
Hypokalemia
8%
Kidney Transplantation
8%
Nephropathy
8%
Neutrophil
8%
Secondary Hyperparathyroidism
7%
Diabetes
7%
Systemic Lupus Erythematosus
7%
Nephrotic Syndrome
6%
Renal Biopsy
6%
Cochlea
6%
Outer Hair Cell
6%
Neurogenic Bladder
6%
Vesicoureteral Reflux
6%
Peritoneal Fibrosis
6%
Central Venous Catheter
6%
Osteoblastogenesis
6%
Adipose-Derived Mesenchymal Stem Cell
6%
Beta Thalassemia
6%
Iron Overload
6%
Troponin T
6%
Dengue Shock Syndrome
6%
Bone Development
6%
Renal Artery Stenosis
6%
Sodium Bicarbonate
6%
Priapism
6%
Tumor Necrosis Factor
6%
Focal Segmental Glomerulosclerosis
6%
Low Drug Dose
6%
Cardiotoxicity
6%
Drug Megadose
6%
Paralysis
6%
Oxidative Stress
6%
Deep Vein Thrombosis
6%
Neoplasm
6%
Maturity Onset Diabetes of the Young
6%
Cell Function
6%
Arterial Stiffness
6%
Patient Referral
6%
Acetic Acid
6%
Flaccid Paralysis
6%
Parathyroidectomy
6%
Non-Hodgkin Lymphoma
6%
Dialysis Fluid
6%
Polycystic Kidney Disease
6%
Doxorubicin
6%
Peritoneal Dialysis
6%
Hypotension
6%
Chronic Myelogenous Leukemia
6%
Digital Imaging
6%
Phosphate Intake
6%
Cation Exchange Resin
6%
Lymphocyte
6%
Cellular Senescence
6%
Myostatin
6%
Somatomedin C
6%
Single Nucleotide Polymorphism
6%
Osteoprotegerin
6%
Receptor
6%
Angiotensin II
6%
Comb
6%
Acetic Acid Ethyl Ester
6%
Serositis
6%
Iron Chelating Agent
6%
Chondrogenesis
6%
Chondrocyte
6%
Kidney Denervation
6%
Glomerular Filtration Rate
6%
Case Presentation
6%
Infection
6%
Isotopes of Calcium
6%
Heart Left Ventricle Ejection Fraction
6%
Albright's Hereditary Osteodystrophy
5%
Erythrocyte
5%
Chelation Therapy
5%
Bone Morphogenetic Protein 2
5%
Prevalence
5%
Pharmacology, Toxicology and Pharmaceutical Science
Hemodialysis
97%
Chronic Kidney Failure
96%
Diseases
28%
Sarcopenia
20%
Acute Kidney Failure
20%
Cross-Sectional Study
16%
Diabetes Mellitus
16%
End Stage Renal Disease
15%
Cohort Study
14%
Myostatin
13%
Coronavirinae
13%
N(g),n(g) Dimethylarginine
13%
6 N,n' Dimethylarginine
13%
Antihypertensive Agent
13%
Disease Exacerbation
13%
Hypertension
13%
Insulin Resistance
13%
Acetylcysteine
13%
Cardiovascular Mortality
13%
Receptor
12%
Creatinine
12%
D Dimer
11%
Parathyroid Hormone
11%
Hyperkalemia
11%
Ureaplasma
10%
Coronary Artery Atherosclerosis
10%
Mortality Rate
10%
Mixed Infection
10%
Infection
9%
Cardiovascular Disease
9%
Proteinuria
9%
Kidney Disease
9%
Randomized Controlled Trial
8%
Hypokalemia
8%
Kidney Injury
8%
Beta Adrenergic Receptor Blocking Agent
7%
Secondary Hyperparathyroidism
7%
Inflammation
7%
8 Hydroxydeoxyguanosine
7%
Nephrotic Syndrome
6%
Homocysteine
6%
Osteodystrophy
6%
Peritoneal Fibrosis
6%
C Reactive Protein
6%
Mus musculus
6%
Annona muricata
6%
Troponin T
6%
Dicarbonate
6%
Deep Vein Thrombosis
6%
Inotropic Agent
6%
Focal Glomerulosclerosis
6%
Cisplatin
6%
Candesartan
6%
Paralysis
6%
Tocilizumab
6%
Iron Poisoning
6%
Chelating Agent
6%
Somatomedin C
6%
Doxorubicin
6%
Cardiotoxicity
6%
Dengue Shock Syndrome
6%
Beta Thalassemia
6%
Dialysis Fluid
6%
Interleukin 6
6%
Flaccid Paralysis
6%
Neoplasm
6%
Nonhodgkin Lymphoma
6%
Antioxidant Capacity
6%
Hypotension
6%
Bacterial Infection
6%
Cation Exchange Resin
6%
Isotopes of Potassium
6%
Non Insulin Dependent Diabetes Mellitus
6%
Osteoprotegerin
6%
Angiotensin II
6%
Isoptera
6%
Macrotermes
6%
Acetic Acid Ethyl Ester
6%
Angiotensin Receptor
6%
Enkephalinase Inhibitor
6%
Resistant Hypertension
6%
Albright Syndrome
5%
Cystatin C
5%
Chelation Therapy
5%